{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:17:23Z","timestamp":1783142243168,"version":"3.54.6"},"reference-count":24,"publisher":"Japan Atherosclerosis Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026,7,1]]},"DOI":"10.5551\/jat.66102","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T22:09:24Z","timestamp":1772834964000},"page":"946-957","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Recurrence Patterns and Treatment Strategies for Reintervention after Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Artery Diseases: Results of the ASTRA Study"],"prefix":"10.5551","volume":"33","author":[{"given":"Naoki","family":"Yoshioka","sequence":"first","affiliation":[{"name":"Department of Cardiology, Ogaki Municipal Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Tokuda","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya Heart Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sendai Kousei Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Bay Urayasu Ichikawa Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saiseikai Yokohama City Eastern Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yanagiuchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rakuwakai Otowa Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ogata","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Miyazaki Medical Association Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Takei","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tenyoukai Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ogaki Municipal Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Nakama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Bay Urayasu Ichikawa Medical Center"},{"name":"Division of Vascular Surgery, Department of Surgery, The Jikei University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsuro","family":"Morishima","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ogaki Municipal Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the LEADers PAD investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y, Schroeder H, Prem JT, Holden A, Popma J, Jaff MR, Diaz-Cartelle J and Muller-Hulsbeck S: A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial. Lancet, 2018; 392: 1541-1551","DOI":"10.1016\/S0140-6736(18)32262-1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) M\u00fcller-H\u00fclsbeck S, Keirse K, Zeller T, Schro\u00eb H and Diaz-Cartelle J: Long-Term Results from the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Femoropopliteal Treatment: 3-Year Follow-up. Cardiovasc Intervent Radiol, 2017; 40: 1832-1838","DOI":"10.1007\/s00270-017-1771-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Schneider PA, Laird JR, Tepe G, Brodmann M, Zeller T, Scheinert D, Metzger C, Micari A, Sachar R, Jaff MR, Wang H, Hasenbank MS and Krishnan P: Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial. Circ Cardiovasc Interv, 2018; 11: e005891","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Sachar R, Soga Y, Ansari MM, Kozuki A, Lopez L, Brodmann M, Schro\u00eb H, Ramanath VS, Diaz-Cartelle J and Zeller T: 1-Year Results From the RANGER II SFA Randomized Trial of the Ranger Drug-Coated Balloon. JACC Cardiovasc Interv, 2021; 14: 1123-1133","DOI":"10.1016\/j.jcin.2021.03.021"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Soga Y, Takahara M, Iida O, Tomoi Y, Kawasaki D, Tanaka A, Yamauchi Y, Tobita K, Kozuki A, Fujihara M and Ando K: Vessel Patency and Associated Factors of Drug-Coated Balloon for Femoropopliteal Lesion. J Am Heart Assoc, 2023; 12: e025677","DOI":"10.1161\/JAHA.122.025677"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Nakama T, Takahara M, Iwata Y, Suzuki K, Tobita K, Hayakawa N, Horie K, Mori S, Obunai K and Ohki T: Low-Dose vs High-Dose Drug-Coated Balloon for Symptomatic Femoropopliteal Artery Disease: The PROSPECT MONSTER Study Outcomes. JACC Cardiovasc Interv, 2023; 16: 2655-2665","DOI":"10.1016\/j.jcin.2023.08.022"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Falkenberg M, James S, Andersson M, Andersson M, Delle M, Engstr\u00f6m J, Fransson T, Gillgren P, Hilbertson A, H\u00f6rer TM, Jacobsson E, Kragsterman B, Lindb\u00e4ck J, Lindgren H, Ludwigs K, Mellander S, Nelz\u00e9n O, Olin R, Sigvant B, Skoog P, Starck J, Tegler G, Thorbj\u00f8rnsen K, Truedson M, Wahlgren CM, Wallinder J, \u00d6jersj\u00f6 A and Nordanstig J: Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, randomised controlled trial. Lancet, 2025; 406: 1103-1114","DOI":"10.1016\/S0140-6736(25)01585-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Nordanstig J, James S, Andersson M, Andersson M, Delle M, Engstr\u00f6m J, Fransson T, Gillgren P, Hilbertson A, H\u00f6rer TM, Jacobsson E, Kragsterman B, Lindb\u00e4ck J, Lindgren H, Ludwigs K, Mellander S, Nelz\u00e9n O, Olin R, Sigvant B, Skoog P, Starck J, Tegler G, Thorbj\u00f8rnsen K, Truedson M, Wahlgren CM, Wallinder J, \u00d6jersj\u00f6 A and Falkenberg M: Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant-masked, registry-based, randomised controlled trial. Lancet, 2025; 406: 1115-1127","DOI":"10.1016\/S0140-6736(25)01584-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Feldman DN, Armstrong EJ, Aronow HD, Gigliotti OS, Jaff MR, Klein AJ, Parikh SA, Prasad A, Rosenfield K, Shishehbor MH, Swaminathan RV and White CJ: SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions. Catheter Cardiovasc Interv, 2018; 92: 124-140","DOI":"10.1002\/ccd.27635"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Yoshioka N, Tokuda T, Tanaka A, Kojima S, Yamaguchi K, Yanagiuchi T, Ogata K, Takei T, Morita Y, Nakama T and Morishima I: Recurrence patterns and clinical outcomes following paclitaxel-coated balloon angioplasty in femoropopliteal artery disease: Results of the CRESCENT study. Vasc Med, 2025; 1358863x251322731","DOI":"10.1177\/1358863X251322731"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Higashino N, Iida O, Ishihara T, Hata Y, Toyoshima T, Tsukizawa T, Nishian K, Fujihara M, Kawasaki D and Mano T: Angiographic patterns of restenosis after drug-coated balloon angioplasty for femoropopliteal lesions and 1-year prognosis after repeat endovascular therapy. Catheter Cardiovasc Interv, 2023; 102: 1114-1121","DOI":"10.1002\/ccd.30856"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Fujihara M, Takahara M, Sasaki S, Nanto K, Utsunomiya M, Iida O and Yokoi Y: Angiographic Dissection Patterns and Patency Outcomes After Balloon Angioplasty for Superficial Femoral Artery Disease. J Endovasc Ther, 2017; 24: 367-375","DOI":"10.1177\/1526602817698634"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Rocha-Singh KJ, Zeller T and Jaff MR: Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv, 2014; 83: E212-220","DOI":"10.1002\/ccd.25387"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Tomoi Y, Soga Y, Imada K, Sakai N, Katsuki T and Ando K: Impact of a Less Than 50% Residual Stenosis Following Vessel Preparation in Femoropopliteal Drug-Coated Balloon Angioplasty. J Endovasc Ther, 2024; 15266028231223086","DOI":"10.1177\/15266028231223086"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Patel MR, Conte MS, Cutlip DE, Dib N, Geraghty P, Gray W, Hiatt WR, Ho M, Ikeda K, Ikeno F, Jaff MR, Jones WS, Kawahara M, Lookstein RA, Mehran R, Misra S, Norgren L, Olin JW, Povsic TJ, Rosenfield K, Rundback J, Shamoun F, Tcheng J, Tsai TT, Suzuki Y, Vranckx P, Wiechmann BN, White CJ, Yokoi H and Krucoff MW: Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol, 2015; 65: 931-941","DOI":"10.1016\/j.jacc.2014.12.036"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Yanagiuchi T, Fukai K, Sogabe K, Iwasaki Y, Hirano K, Kato T, Yokoi H, Zen K and Matoba S: Predictors of recurrent restenosis after repeat drug-coated balloon therapy for drug-coated balloon restenosis in femoropopliteal lesions: Results of the RECURRENCE study. Catheter Cardiovasc Interv, 2024; 104: 1241-1250","DOI":"10.1002\/ccd.31245"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Haraguchi T, Tsujimoto M, Kashima Y, Sato K and Fujita T: Repeat drug-coated balloon angioplasty for femoropopliteal lesions: 12-month results from a retrospective observational study. CVIR Endovasc, 2024; 7: 24","DOI":"10.1186\/s42155-024-00434-w"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Iida O, Takahara M, Soga Y, Yamaoka T, Fujihara M, Kawasaki D, Ichihashi S, Kozuki A, Nanto S, Sakata Y and Mano T: 1-Year Outcomes of Fluoropolymer-Based Drug-Eluting Stent in Femoropopliteal Practice: Predictors of Restenosis and Aneurysmal Degeneration. JACC Cardiovasc Interv, 2022; 15: 630-638","DOI":"10.1016\/j.jcin.2022.01.019"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Fujihara M, Takahara M, Iida O, Kawasaki D, Soga Y, Tobita K, Horie K, Takagi T, Okamoto S, Nakama T, Sasaki S, Tsubakimoto Y and Suematsu N: Endovascular Therapy with Interwoven Nitinol Stent Placement after Predilation for Heavily Calcified Femoropopliteal Artery Disease: Results of the BURDOCK Study. J Vasc Interv Radiol, 2023; 34: 1929-1937","DOI":"10.1016\/j.jvir.2023.07.023"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Kurata N, Iida O, Takahara M, Asai M, Okamoto S, Ishihara T, Nanto K, Tsujimura T, Hata Y, Toyoshima T, Higashino N, Nakao S and Mano T: Comparing Predictors Influencing Restenosis Following High-Dose Drug-Coated Balloon Angioplasty and Fluoropolymer-Based Drug-Eluting Stenting in Femoropopliteal Artery Lesions. J Endovasc Ther, 2025; 32: 1194-1204","DOI":"10.1177\/15266028231209234"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Nordanstig J, Behrendt CA, Baumgartner I, Belch J, B\u00e4ck M, Fitridge R, Hinchliffe R, Lejay A, Mills JL, Rother U, Sigvant B, Spanos K, Szeberin Z, van de Water W, Antoniou GA, Bj\u00f6rck M, Gon\u00e7alves FB, Coscas R, Dias NV, Van Herzeele I, Lepidi S, Mees BME, Resch TA, Ricco JB, Trimarchi S, Twine CP, Tulamo R, Wanhainen A, Boyle JR, Brodmann M, Dardik A, Dick F, Go\u00ebffic Y, Holden A, Kakkos SK, Kolh P and McDermott MM: Editor\u2019s Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication. Eur J Vasc Endovasc Surg, 2024; 67: 9-96","DOI":"10.1016\/j.ejvs.2023.08.067"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22) Tobita K, Takahara M, Soga Y, Iida O, Tanaka A, Yamauchi Y, Kawasaki D, Fujihara M, Kozuki A and Saito S: Effectiveness of cilostazol treatment in femoropopliteal artery disease after drug-coated balloon therapy: Subanalysis of the POPCORN study. J Vasc Surg, 2025; doi: 10.1016\/j.jvs.2025.08.020","DOI":"10.1016\/j.jvs.2025.08.020"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Yoshioka N, Tokuda T, Tanaka A, Kojima S, Yamaguchi K, Yanagiuchi T, Ogata K, Takei T, Morita Y, Nakama T and Morishima I: Patterns and Timings of Recurrence After Fluoropolymer-Coated Drug-Eluting Stent Use for Femoropopliteal Artery Diseases - Results of the PLANET Study. Circ J, 2025; 89: 574-583","DOI":"10.1253\/circj.CJ-25-0054"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Takei T, Tokuda T, Yoshioka N, Ogata K, Tanaka A, Kojima S, Yamaguchi K, Yanagiuchi T and Nakama T: Effects of statin therapy in patients treated with drug-eluting and drug-coated stents for femoropopliteal lesions. J vasc Surg, 2025; 82:559-568","DOI":"10.1016\/j.jvs.2025.03.057"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/7\/33_66102\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:45:28Z","timestamp":1783140328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/7\/33_66102\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.66102","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"article-number":"66102"}}